In the first part of our interview with James Burt – Accord’s executive vice-president for Europe, the Middle East and North Africa – he laid out the key actions taken by the European generics industry to mitigate the coronavirus pandemic over the past weeks and months. (Also see "European Industry Played Key Role In Mitigating COVID-19" - Generics Bulletin, 30 July, 2020.)
Now, in the second part of our exclusive interview, Burt tells Generics Bulletin what the off-patent industry can expect in...



